S.R. Foley

6.4k total citations
53 papers, 1.2k citations indexed

About

S.R. Foley is a scholar working on Organic Chemistry, Oncology and Hematology. According to data from OpenAlex, S.R. Foley has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 17 papers in Oncology and 10 papers in Hematology. Recurrent topics in S.R. Foley's work include Organometallic Complex Synthesis and Catalysis (14 papers), CAR-T cell therapy research (13 papers) and Coordination Chemistry and Organometallics (7 papers). S.R. Foley is often cited by papers focused on Organometallic Complex Synthesis and Catalysis (14 papers), CAR-T cell therapy research (13 papers) and Coordination Chemistry and Organometallics (7 papers). S.R. Foley collaborates with scholars based in Canada, United States and Australia. S.R. Foley's co-authors include D.S. Richeson, Glenn P. A. Yap, Richard F. Jordan, J. Wilson Quail, Robert A. Stockland, Han Shen, Corinne Bensimon, Gilles P. Robertson, Michael D. Guiver and J.M. Chitanda and has published in prestigious journals such as Journal of the American Chemical Society, Blood and PLoS ONE.

In The Last Decade

S.R. Foley

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.R. Foley Canada 21 877 434 179 128 91 53 1.2k
Ari Lehtonen Finland 20 671 0.8× 664 1.5× 118 0.7× 567 4.4× 445 4.9× 90 1.6k
Tianshu Li United States 18 480 0.5× 463 1.1× 73 0.4× 249 1.9× 469 5.2× 27 1.5k
Bernd Morgenstern Germany 21 425 0.5× 409 0.9× 26 0.1× 183 1.4× 297 3.3× 140 1.7k
Bjorn Askevold Germany 12 774 0.9× 620 1.4× 163 0.9× 192 1.5× 244 2.7× 13 1.5k
Renee M. Thomas United States 11 507 0.6× 121 0.3× 235 1.3× 27 0.2× 39 0.4× 15 710
D. Konya Hungary 11 289 0.3× 161 0.4× 57 0.3× 57 0.4× 57 0.6× 14 774
Tingting Chen China 18 441 0.5× 247 0.6× 46 0.3× 47 0.4× 443 4.9× 56 1.2k
Yanfeng Jiang China 17 639 0.7× 446 1.0× 259 1.4× 56 0.4× 268 2.9× 46 1.1k
Sanrong Liu China 18 390 0.4× 85 0.2× 238 1.3× 33 0.3× 102 1.1× 39 977

Countries citing papers authored by S.R. Foley

Since Specialization
Citations

This map shows the geographic impact of S.R. Foley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.R. Foley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.R. Foley more than expected).

Fields of papers citing papers by S.R. Foley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.R. Foley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.R. Foley. The network helps show where S.R. Foley may publish in the future.

Co-authorship network of co-authors of S.R. Foley

This figure shows the co-authorship network connecting the top 25 collaborators of S.R. Foley. A scholar is included among the top collaborators of S.R. Foley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.R. Foley. S.R. Foley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landsburg, Daniel J., Matthew J. Frigault, S.R. Foley, et al.. (2025). Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry. Journal for ImmunoTherapy of Cancer. 13(2). e009890–e009890. 3 indexed citations
2.
Landsburg, Daniel J., Amy Moskop, S.R. Foley, et al.. (2024). Durable Efficacy and Manageable Safety in Patients Age ≥75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting. Transplantation and Cellular Therapy. 30(2). S187–S188.
3.
Kong, Dexu, S.R. Foley, & Lee D. Wilson. (2024). Cross-linked chitosan as biomacromolecular adsorbents for adsorption of precious metal-chloride complexes from aqueous media. International Journal of Biological Macromolecules. 291. 138962–138962. 8 indexed citations
4.
Visram, Alissa, Hsien Seow, Gregory R. Pond, et al.. (2023). Treatment Patterns and Healthcare Resource Utilization Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study. Blood. 142(Supplement 1). 3774–3774. 1 indexed citations
5.
Singh, Kanwaldeep, Emily Hartung, Islam Alshamleh, et al.. (2023). LSD1 Inhibition Synergizes with Venetoclax in Acute Myeloid Leukemia By Targeting Cellular Metabolism. Blood. 142(Supplement 1). 4156–4156. 1 indexed citations
6.
Landsburg, Daniel J., Amy Moskop, S.R. Foley, et al.. (2023). Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting. Blood. 142(Supplement 1). 3496–3496. 2 indexed citations
7.
Felizardo, Tania C., C. Anthony Rupar, S.R. Foley, et al.. (2022). Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders. EMBO Molecular Medicine. 14(4). e14297–e14297. 9 indexed citations
8.
Cummings, Derek T., Galina Denisova, Michael Sun, et al.. (2021). Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma. Cytotherapy. 23(9). 820–832. 9 indexed citations
9.
Awasthi, Rakesh, Constantine S. Tam, Ulrich Jaeger, et al.. (2018). Clinical pharmacology of tisagenlecleucel (CTL019) in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL). Clinical Trials. 78(13).
10.
Awasthi, Rakesh, Constantine S. Tam, Ulrich Jaeger, et al.. (2017). Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 130. 5211–5211. 1 indexed citations
11.
Barth, David, et al.. (2015). Absence of Viral Complications When Using Rituximab to Treat TTP with Plasma Exchange. Blood. 126(23). 2261–2261. 1 indexed citations
12.
Auray‐Blais, Christiane, Michel Boutin, Paméla Lavoie, et al.. (2013). Gene therapy for Fabry disease patients: The importance of efficient biomarker monitoring. Molecular Genetics and Metabolism. 108(2). S21–S21. 1 indexed citations
13.
Quail, J. Wilson, et al.. (2011). Bis-diimidazolylidine complexes of nickel: Investigations into nickel catalyzed coupling reactions. Dalton Transactions. 41(1). 251–260. 42 indexed citations
14.
Chitanda, J.M., et al.. (2011). Synthesis of mixed N,N′-(Ar,Ar′-diaryl)iminoisoindolines for applications in palladacycle formations. Inorganica Chimica Acta. 379(1). 122–129. 11 indexed citations
15.
Foley, S.R., Kathryn E. Webert, Donald M. Arnold, et al.. (2009). A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura. Kidney International. 75(112). S55–S58. 15 indexed citations
16.
Denisova, Galina, et al.. (2009). Characterizing Complex Polysera Produced by Antigen-Specific Immunization through the Use of Affinity-Selected Mimotopes. PLoS ONE. 4(4). e5309–e5309. 4 indexed citations
17.
Chitanda, J.M., Demyan E. Prokopchuk, J. Wilson Quail, & S.R. Foley. (2008). Synthesis of palladacycles employing iminoisoindolines as monoanionic bidentate ligands. Dalton Transactions. 6023–6023. 28 indexed citations
18.
Quail, J. Wilson, et al.. (2008). Non-symmetrically substituted di-N-heterocyclic carbene palladium(II) complexes: Synthesis, structure and catalytic activity. Journal of Organometallic Chemistry. 693(21-22). 3405–3410. 28 indexed citations
19.
Quail, J. Wilson, et al.. (2008). Copper(II) Ethylene Polymerization Catalysts: Do They Really Exist?. Organometallics. 27(20). 5333–5338. 35 indexed citations
20.
Chitanda, J.M., J. Wilson Quail, & S.R. Foley. (2008). N-(2,6-Diisopropylphenyl)formamide. Acta Crystallographica Section E Structure Reports Online. 64(9). o1728–o1728. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026